ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0060088;auditory receptor cell stereocilium organization;7.0;1.0;0.8509193652572005;9.628524252492122;22.00145371568439;7.379178354882098;7.363688558411388E-4;0.728290889492758;[CLIC5, MYO7A]
GO:0014066;regulation of phosphatidylinositol 3-kinase signaling;7.0;0.8933024483968273;0.7975705894556142;9.427853557029971;45.070113835906206;5.202362649177086;0.001508456149618737;0.6169684330707209;[PDGFRB, BECN1, NCF1, PIK3IP1, CCL5, IER3]
GO:0014065;phosphatidylinositol 3-kinase signaling;8.0;1.0;0.875;9.628524252492122;26.42836680105094;6.343086423195323;8.845336528452411E-4;0.6993857346658935;[C1QBP, SIRT2, IGF1R]
GO:0051291;protein heterooligomerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;5.113634533568402;0.00140677858073304;0.5846318204451575;[RRM1, CPSF6, COL1A2, YWHAB, NUP62, RIPK1, IKZF1, HSD17B8, PRKAB1]
GO:0006886;intracellular protein transport;8.0;0.5537205960740763;0.6518602980370382;8.117066748418225;90.55259897265384;3.0436717358431102;0.0030307139955665606;0.5306535141162272;[RAB3B, AHCYL1, RPL3, NCF1, ZDHHC6, IPO4, RAB43, RPH3A, IPO8, LAMP2, LONP2, ARFIP1, HOMER3, TBC1D22A, VPS18, GSTK1, RPS9, COG3, AP1B1, TBC1D2B, MYO7A, SYTL3, BCR, CHMP4B, SLC27A2, KPNB1, ACOT4, COPB2, COPA, VPS26B, VPS11, RAB6A, VPS16, PMM1, RAB3IP, NUP153, RAB27B, TIMM44, NFKBIA, PAN3, NPLOC4, CDK5, BCL3, ARF3, TRAM1, YWHAB, SRP54, CLTA, AP1G2, AP1G1, NUP62, KIF13B, TMED2, TMED1, EVI5L, TNPO1, TNPO2, RAB8B, TMED4, GRIPAP1, TMED9, SEC13, SSR2, TBC1D8, ACOX2, AGPS, SLU7, RABGAP1, ZDHHC23, HSD17B4, ZDHHC24, DERL2, TRAK1, RGPD1, NAPG, STX11, ARNTL, RAB21, AP3M1, RAB20, GGA3, LMNA, AP2S1, HEATR3, STX5, RAB28, BID, RAE1, RPL19, PEX16, TIMM8B, PEX19, SYVN1, RPL23A, RAB11A, ARCN1, SPCS2, SNX17, VPS41, RAB13, TAOK2, RAB18, RUNDC1, RAB3GAP2, SEC24C]
GO:0007216;G-protein coupled glutamate receptor signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.427853557029971;54.172554706560106;7.069023426578259;0.0018131066538945874;0.7124295520356204;[HOMER3, DAGLB]
GO:0051091;positive regulation of DNA binding transcription factor activity;11.0;0.811012628672052;0.8379352666656883;9.431813958246067;277.8307104044464;4.2636448815154875;0.00929874384583087;0.650471949850128;[MTPN, CRTC2, ITGB2, CIB1, NLRC4, LRP8, RELA, STK3, MTDH, RPS6KA4, EP300, NLRP3, RIPK1, CYTL1, UBE2I, BUD31, SPHK1, TMEM173, PPRC1, NFKB1, IL6, COPS5, TRIM14, KRAS, TRIM32, ARHGEF5]
GO:0006559;L-phenylalanine catabolic process;10.0;0.9326813400603323;0.8815816818910864;9.59953671561887;1267.4995185646956;7.379178354882098;0.04242206821085258;0.7926125360964777;[HPD]
GO:0045892;negative regulation of transcription, DNA-templated;10.0;0.556709148698489;0.6935955862101648;8.520155788878647;1581.2569993850602;2.683669001811703;0.05292324873051003;0.5524839694169422;[NAB1, GFI1, GMNN, ARID4A, IKZF1, IKZF2, YY1, SAP130, DPF2, TRIM24, WWC3, EP300, SOX8, ZNF564, TLE4, ZNF282, RUNX2, EID1, ILF3, SFRP1, BRMS1, ZNF93, TBL1XR1, PSPC1, HOXB4, TIMELESS, PPID, MAX, FOXG1, SUPT6H, MTDH, BAG3, TPR, HIVEP1, HESX1, SUDS3, TFAP2A, DR1, CREBBP, UBE2I, XRCC5, NONO, H3F3A, NFKB1, CDK5, CNOT1, PKIA, SP3, BCL3, ZNF658, NFE2L3, EZH2, CDKN1C, USP36, CIITA, BTG2, YWHAB, OTUD7B, FLCN, NIPBL, C1QBP, LRRFIP1, HIF1AN, CIC, DACT1, ZNF485, TSC22D4, KLF12, PEG3, ARID1A, SIRT2, DUSP22, NCOR1, TFDP2, MTF2, LCOR, HDAC3, ZNF350, HDAC1, LRP8, RELA, ARNTL, BCLAF1, RXRA, MTA2, E2F7, ZNF189, E2F8, IRX1, NFYC, PER2, CENPF, GFI1B, HIST3H2A, NFIB, NFIC, TAF7, LIMS1]
GO:0006914;autophagy;4.0;0.6729672293956388;0.5864836146978194;8.39638057119949;37.75222312160081;4.39717627414001;0.001263532933085;0.4748717991491287;[VPS18, BECN1, GABARAPL1, CALCOCO2, ITGB4, VTA1, CLEC16A, PTPN22, PGA3, FNBP1L, DYNLL2, PRKAB1, PGA5, SIRT2, CLN3, VPS41, LAMP2, VPS11, UBQLN1, C6orf106, CHMP4B, PIK3C3, CHMP6, MARK2]
GO:0048563;post-embryonic animal organ morphogenesis;4.0;0.7192862368539868;0.6096431184269935;8.347590407030058;28.880759128360687;7.697632086000634;9.66613017030495E-4;0.6436572628545723;[MYO7A]
GO:0070885;negative regulation of calcineurin-NFAT signaling cascade;10.0;1.0;0.9152410118609203;9.628524252492122;339.10982455209705;7.292166977892469;0.011349700648730492;0.7881627702307852;[HOMER3]
GO:2001020;regulation of response to DNA damage stimulus;6.0;0.5902001590945054;0.6182203921373972;8.01908634005802;29.43425144606613;4.530049555519983;9.851379067933503E-4;0.5547872575282844;[POLQ, SMG1, FBXO18, DTX3L, EYA2, WRNIP1, TFIP11, DEK, SENP2, CDK9, RAD51AP1, BCLAF1, RAD51, TIMELESS, USP51, BID, TRIM32, ZNF365, IER3]
GO:0007264;small GTPase mediated signal transduction;6.0;0.7369933605727446;0.6916169928765168;8.741221057491218;26.42836680105094;4.015022244900292;8.845336528452411E-4;0.5284487369119741;[RAB3B, NCKAP1, CDKN1A, ROCK2, DOCK8, RASGRP2, RASGRP4, RAB21, RAB43, RAP1B, ABR, DOCK11, RHOT2, RHOT1, RAB20, RRAS, ARHGDIB, CFL1, RAB28, RAB6A, RAB8B, KSR1, SETDB1, RAB27B, VAV1, RAB11A, NISCH, COL1A2, ALS2, RAB13, RAB18, ELMO1, TAX1BP3, KRAS, ARHGEF1, DOCK2, RGL1, KPNB1]
GO:1900740;positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway;10.0;1.0;0.9152410118609203;9.628524252492122;990.0589542238915;6.599019797332524;0.033136382202663156;0.7527151911823093;[TFDP2, YWHAB, TP53BP2, BID, YWHAZ, BBC3]
GO:0048009;insulin-like growth factor receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;31.002284443533863;7.138016298065211;0.0010376185600805164;0.7400384854347593;[EIF2AK3, IGF1R]
GO:0042462;eye photoreceptor cell development;6.0;0.7866048967936545;0.7164227609869718;8.999915593069748;34.925795330556404;6.280566066213989;0.00116893493853861;0.6443087532925187;[GNAT2, MYO7A]
GO:0006572;tyrosine catabolic process;9.0;0.8933024483968273;0.8428918493787028;9.56398573135455;1103.2577725762135;7.9853141584524145;0.03692504478059296;0.8046099625986299;[HPD]
GO:0006012;galactose metabolic process;6.0;0.7763722522362496;0.7113064387082693;9.0689084645567;34.676020684410545;7.069023426578259;0.0011605752059146955;0.6846304993685643;[SLC35A2]
GO:0097062;dendritic spine maintenance;7.0;1.0;0.8509193652572005;9.628524252492122;53.70815772734724;7.474488534686424;0.0017975637049304797;0.7331650565203278;[IGF1R]
GO:0097186;amelogenesis;6.0;1.0;0.8231203125901445;9.628524252492122;26.73958370240551;7.474488534686424;8.949498024565515E-4;0.7053660038532718;[ITGB4]
GO:0006605;protein targeting;9.0;0.7192862368539868;0.7558837436072825;9.182237149863703;93.4429707305496;4.015022244900292;0.0031274521371376313;0.6015690495021188;[TRAM1, RPL3, NCF1, YWHAB, ZDHHC23, SRP54, HSD17B4, ZDHHC24, ZDHHC6, TRAK1, AP3M1, LAMP2, KIF13B, LONP2, HOMER3, BID, RAB8B, RPL19, PEX16, TIMM8B, GSTK1, RPS9, PEX19, PMM1, SSR2, RAB3IP, RPL23A, TIMM44, SPCS2, PAN3, ACOX2, VPS41, AGPS, TAOK2, CHMP4B, SLC27A2, ACOT4]
GO:0071560;cellular response to transforming growth factor beta stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;5.788089581116195;0.003262744749111514;0.6191234829421188;[SFRP1, CLEC3B, LIMS1]
GO:0072334;UDP-galactose transmembrane transport;8.0;0.9326813400603323;0.8413406700301662;9.567899630675686;142.06452249237992;9.083926447120524;0.004754771718050423;0.839552420951524;[SLC35A2]
GO:0048333;mesodermal cell differentiation;4.0;0.8259837884571596;0.6629918942285797;8.935377071932177;21.066225782797595;7.138016298065211;7.050676185779127E-4;0.6150384854347593;[ITGB4, ITGB3, ITGA2]
GO:0035308;negative regulation of protein dephosphorylation;9.0;0.8259837884571596;0.8092325194088689;9.4949928598676;662.4833200147516;5.71663061713405;0.022172720524614064;0.6885893807910348;[PPP1R11, ROCK2, PPME1, YWHAB, PHACTR2, NCKAP1L]
GO:0010469;regulation of signaling receptor activity;6.0;0.5916390046238794;0.6189398149020842;7.95454781892045;48.619731222684926;3.470798340732454;0.0016272586491059737;0.5006171011438312;[CMTM7, ERRFI1, COPA, UBE2I, NCF1, CCL20, BUD31, EBI3, FLT3LG, IL27, IL6, GAL, CDK5, IL23A, CCL5, NPPA, FAM3C, CCL19, CHMP6, KCNK3, HBEGF]
GO:0030335;positive regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.22453031427283;157.26390226612122;3.6656062881777913;0.005263481280523835;0.5383786413027378;[CD151, ONECUT2, ROCK2, DOCK8, ITGB3, CIB1, CD99L2, THBS1, CORO1A, IGF1R, NIPBL, C1QBP, CCL5, CTSH, NCKAP1L, CCL19, ATP7A, CLASP1, CCR2, SEMA6B, PDGFRB, MAP3K3, IGFBP5, CCL20, ITGA2, SPHK1, RAB11A, PTP4A1, VIL1, CREB3, IL6, P2RX4, KARS, SP1, IL23A, RUFY3, EPHA1, MAPRE1, TRIM32, HBEGF]
GO:0016567;protein ubiquitination;9.0;0.6913464685778243;0.7419138594692012;8.996001693748612;153.79381005389072;3.300101264790787;0.005147340417060716;0.5650079573320931;[PPP1R11, CCNF, UBE2Z, UBE2L3, TRIM9, NPEPPS, HERC4, TRIM7, HERC1, CDC26, TRIM24, TRIM69, SKP2, C18orf25, RNF44, FBXO18, DTX3L, ARRDC1, ZFP91, TRPC4AP, DDB1, KCTD10, MED20, ANAPC5, HIST1H2BC, HIST1H2BO, HIST1H2BJ, CDCA3, MGRN1, RNF38, UBR4, NEDD8, DTX2, KLHL12, NLRC4, ANAPC11, VCPIP1, RNF213, UBD, HLTF, RFFL, RNF20, UBE2I, UBE2B, KLHL25, SYVN1, FBXL15, LNPEP, FBXL16, MARCH3, CNOT4, ITCH, SPSB1, RNF103, UBE2T, TSPAN17, KBTBD2, FBXL3, TRIM32, ASB3]
GO:0031581;hemidesmosome assembly;6.0;1.0;0.8231203125901445;9.628524252492122;36.796901128588246;7.292166977892469;0.0012315591657128446;0.6960420709600095;[CD151, ITGB4]
GO:0006383;transcription by RNA polymerase III;10.0;0.8436909121759173;0.837086467948879;9.499312521012115;583.8786478812184;6.113511981550823;0.01954189288791682;0.7278862989048107;[GTF3C1, ZNF143, TBP, ELL, POLR3C, POLR3E]
GO:0008286;insulin receptor signaling pathway;8.0;0.8653626801206646;0.8076813400603323;9.34084218004034;31.002284443533863;5.346256828837156;0.0010376185600805164;0.6484078228531001;[PTPRA, ATP6V1F, IGF1R]
GO:0008284;positive regulation of cell proliferation;5.0;0.5587538620495764;0.5696179428857084;7.270369308343265;43.45254999490143;2.9881018846882994;0.0014543177435732513;0.44305268120482816;[CDKN1A, WDR48, TFRC, ITGB3, CD80, SIRPG, CCNF, KIF14, CIB1, IGF1R, TIAL1, PPP1CC, LBH, FNTB, CTSH, SOX8, ATP7A, SKP2, CCR2, HLA-DPA1, HAVCR2, PDGFRB, RPS9, TIPIN, CSNK2A1, IGFBP5, SPHK2, ITGA2, SPHK1, TBC1D8, ARNT, FLT3LG, PDCD1LG2, RUNX2, ERN1, SFRP1, CCNE2, IL23A, EPHA1, HBEGF, HDAC1, FOXG1, EBI3, DERL2, CRIP2, THBS1, CORO1A, RELA, CCNB1, HLA-DMB, CCL5, NCKAP1L, CCL19, TBX1, MAP3K3, CDC7, TSHR, CNOT6, CD4, IL6, SP1, HLA-DPB1, KRAS, CNOT8, CCNJL]
GO:0006464;cellular protein modification process;6.0;0.33881133730344803;0.4925259812418685;5.842712558201993;147.0276183392271;1.7630686329010112;0.004920882069548126;0.41328372446777834;[OXTR, MAML1, CCNH, CCNF, ZDHHC5, ZDHHC6, UBE2L3, PSMD8, RPS6KA4, HERC4, PSMD7, HERC1, PSMD4, RPS6KA2, PSMD2, CDC26, TRIM24, SKP2, CSNK2A1, ARRDC1, SLC35C2, COG3, NSMCE2, PRKAB1, BCR, KARS, KCTD10, PSME2, EPHA1, CDCA3, FUT11, RPN1, COPS7A, ANAPC11, C3, TGOLN2, NUAK1, RHOT1, RNF213, HLTF, STK38L, CREBBP, PMM1, SETDB1, EDEM1, EIF2AK3, LNPEP, CDC7, ERLIN2, SETX, RNF103, FBXL3, CALM1, EZH2, PIGS, BTG2, SMG1, WDR48, PIGT, SETD3, PPP1R11, GPAA1, SERPINA10, OTUD7B, TRIM9, AKAP13, UBL5, ZMYM2, TRIM7, CTSH, PCMTD1, VKORC1, JOSD1, GFRA2, SIRT2, DDB1, GAK, ITPKB, PSMA1, PDIK1L, MED20, FASTKD5, HBEGF, CSTA, DERL3, ZDHHC23, ZDHHC24, DERL2, NEDD8, TRAK1, PSMA7, PPP2CA, PSMB5, PSMB1, APOL1, MAP3K3, EGLN2, SYVN1, DOHH, GTF2H4, RAB11A, PER2, ITCH, SPSB1, CAMK4, PSMC1, KBTBD2, TAOK2, CAMK1, RAB3B, GALNT12, CRTC2, ARID4A, IL5RA, BUB1B, STK19, UBE2Z, GALNT10, IGF1R, YY1, PPP1CB, PPP1CC, NPEPPS, PPME1, FNTB, CFL1, EP300, TGM6, C18orf25, PDGFRB, RNF44, FBXO18, IGFBP5, VPS33B, SSU72, VRK2, TRPC4AP, CDC25A, PIAS2, ERN1, DPM3, ILF3, BRMS1, TBL1XR1, ANAPC5, PPID, CSNK1G2, HIST1H2BC, CSNK1G1, UBR4, DTX2, KLHL12, PKMYT1, RLF, RASGRP4, FUT4, STK3, VCPIP1, CCNB1, STK35, UBD, STK38, NLRP3, USP51, MBP, RIPK1, SUDS3, RAB6A, MARK2, DR1, UBE2I, TOR1A, UBE2B, KLHL25, AMBP, RHBDD1, DOLK, CLK4, SSH3, CLK3, NFKB1, MARCH3, CLK1, CDK9, NFKBIA, CNOT4, IL6, PAN3, COPS5, CDK5, PTPRA, MAN2B2, FES, UBE2T, MAN2B1, USP36, PRKCSH, MAST3, USP32, YWHAB, USP34, PTPN22, USP39, MSLN, DUSP14, SENP6, POLB, PPP6C, SUMO3, TRIM69, HIF1AN, ATP7A, USP46, FGA, KSR1, DTX3L, FGG, CAD, ZFP91, DUSP28, RAD23A, PPP2R5D, OXSR1, SENP2, SPTB, PTP4A1, DUSP22, DUSP23, CTDSP2, PIK3C3, ETF1, MAN1B1, USP41, BECN1, HDAC3, HIST1H2BO, ITIH2, HIST1H2BJ, HDAC1, ROCK2, MGRN1, RNF38, USP12, NLRC4, THBS1, PSMB10, PPM1G, TFPT, PABPN1, RBBP5, CCL5, MKNK2, NCAM1, CSK, RFFL, MTA2, RNF20, EYA2, FBXL15, FBXL16, POLE4, SNRK, TNIP2, TSPAN17, RAB13, MGAT4B, CCM2, KRAS, TRIM32, ASB3]
GO:0002062;chondrocyte differentiation;4.0;0.8933024483968273;0.6966512241984136;9.446202695698167;21.066225782797595;6.039404009397101;7.050676185779127E-4;0.5588554019015759;[SNX19, NFIB, CYTL1, RUNX2]
GO:0043243;positive regulation of protein complex disassembly;6.0;0.7192862368539868;0.682763431017138;8.781226392104918;65.71852696664936;6.250713103064308;0.002199539954739362;0.6427820713687392;[SETX, VIL1, WDR1, CALCOCO2, CFL1, CLEC16A, IGF1R]
GO:0043488;regulation of mRNA stability;9.0;0.7436939687323844;0.7680876095464813;9.240758721483358;282.23354693635815;4.989581884898423;0.009446102822258332;0.6514080748132811;[FXR1, UPF1, XRN1, YTHDF3, YWHAB, DCP1A, TNPO1, EXOSC3, YWHAZ, DCP2]
GO:0042795;snRNA transcription by RNA polymerase II;12.0;1.0;0.9481203125901445;9.628524252492122;1410.6487555617684;5.528578385631111;0.047213144347195396;0.730852068336507;[CDK9, ZNF143, TBP, ELL, POLR2B, SP1, INTS3, INTS10, INTS4, POLR2G, GTF2E2]
GO:0045625;regulation of T-helper 1 cell differentiation;12.0;0.8933024483968273;0.8947715367885583;9.55953138100517;277.2071189577665;7.474488534686424;0.009277872801306361;0.8303660038532719;[IL4R, CD80, IL27, CCL19]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[CRTC2, MAML1, CCNH, GFI1, ARID4A, RORA, IKZF1, IKZF2, ELK1, YY1, RPS6KA4, DPF2, EP300, SOX8, IER5, ZNF564, IER2, FLT3LG, MED6, RUNX2, PIAS2, ARMCX3, IL23A, TBL1XR1, RFX4, HOXB4, MAX, RLF, SUPT6H, RAD21, HLTF, SCAP, NLRP3, RIPK1, CYTL1, TFAP2A, ZBTB17, ZNF143, DR1, CREBBP, PBX3, ERLIN2, FLI1, NFKB1, SETX, CDK9, NFKBIA, IL6, STAG1, TFCP2, COPS5, SP1, SP3, MAFF, BCL3, NFE2L1, CIITA, SETD3, ONECUT2, ELL, DDX41, HOXC13, AATF, FLCN, NIPBL, ZNF485, KLF13, PEG3, NCOA6, MKL1, ARNT, SENP2, SAFB, TMEM173, PPRC1, SIRT2, CREB3, GAL, TFDP2, ELF4, MTF2, TFEC, HDAC3, ZNF350, HDAC1, WBP2, RELA, ARNTL, RXRA, MTA2, E2F7, E2F8, TBX1, ZNF462, NFYC, ATAD2, ARID3B, GRHL1, USF2, NFIB, TNIP2, NFIC, PSMC1, TAF7, CAMK1]
GO:0045744;negative regulation of G-protein coupled receptor protein signaling pathway;7.0;0.6467165523344657;0.6742776414244334;8.623002386890024;189.85671913105512;6.166155715036245;0.006354333529362364;0.6662568552797195;[MGRN1, YWHAB, CCL5]
GO:0000398;mRNA splicing, via spliceosome;11.0;0.8259837884571596;0.845420846558242;9.4949928598676;356.66873027722005;4.19357731889877;0.011937381421361158;0.6468886914394342;[SF3B5, SF3B2, WBP4, EIF4A3, DDX23, DDX42, DDX41, CASC3, USP39, EFTUD2, UBL5, PABPN1, PCF11, U2AF2, POLR2B, DHX16, SNRPB2, POLR2G, SMNDC1, RBM5, AQR, PRPF38A, GPKOW, BUD31, CPSF3, NONO, CPSF2, TFIP11, LSM5, SRRM1, PSPC1, PRPF3, SNRPG, CD2BP2, SLU7]
GO:0051389;inactivation of MAPKK activity;12.0;1.0;0.9481203125901445;9.628524252492122;2444.6724912788027;9.083926447120524;0.08182098822069953;0.9126727335416687;[IGF1R]
GO:0002576;platelet degranulation;8.0;1.0;0.875;9.628524252492122;39.85546922145481;4.956792062075433;0.0013339266872485146;0.6284905765689417;[FGA, SERPINA3, WDR1, ITGB3, FGG, RAB27B, THBS1, CLEC3B, LAMP2, CD9, PHACTR2, FAM3C, CALM1, ALDOA, A2M]
GO:0000165;MAPK cascade;9.0;0.7436939687323844;0.7680876095464813;9.236482164716097;231.45054935470895;4.069963362931594;0.007746441594931149;0.6043787408332628;[OXTR, YWHAB, IL5RA, RASGRP4, PABPN1, CCL5, CTSH, NCAM1, MBP, RIPK1, PDGFRB, MAP3K3, KSR1, GFRA2, SPTB, NFKB1, SETX, ITPKB, KARS, PTPRA, TNIP2, TAOK2, CCM2, KRAS, CALM1, HBEGF]
GO:0007229;integrin-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;5.311165509025885;8.87013979980389E-4;0.5947335637161829;[FCER1G, ITGB4, ITGB3, ITGA2, ITGB2, NEDD9, CCM2, VAV1]
GO:0050650;chondroitin sulfate proteoglycan biosynthetic process;8.0;1.0;0.875;9.628524252492122;493.6124881072737;7.697632086000634;0.016520765754552514;0.7686572628545723;[CYTL1]
GO:0032703;negative regulation of interleukin-2 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;6.7325511899570465;0.002184000309729388;0.6674232935401965;[LAG3, HOMER3, HAVCR2]
GO:0045078;positive regulation of interferon-gamma biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.8798377098682;7.212124270218933;0.027942676825076673;0.7438283705770736;[EBI3, IL27]
GO:0071277;cellular response to calcium ion;6.0;1.0;0.8231203125901445;9.628524252492122;78.50383844342444;5.433268205826786;0.0026274528238337297;0.6009779013089371;[ITPKB, CPNE2, ECT2, ARID1A, RASGRP2]
GO:0051262;protein tetramerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;4.917261223318797;0.00140677858073304;0.5745892802266999;[VASP, RRM1, CRTC2, CPSF6, ATPIF1, HSD17B8, GLS, IGF1R, RXRA, ALDH5A1, IMPDH2, CCL5, ALDOA]
GO:0001845;phagolysosome assembly;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;81.92137458931388;8.16763571524637;0.002741834683053802;0.7686126355688037;[MYO7A, CORO1A]
GO:0051904;pigment granule transport;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;93.62123251006847;6.641579411751319;0.003133418398472942;0.6905700452391912;[BBS2, RAB27B, MYO7A, RAB11A]
GO:0033674;positive regulation of kinase activity;9.0;0.6073376606709605;0.6999094555157693;8.620883742029738;265.89784403492143;3.4106031799490317;0.008899361547325376;0.5706590304121504;[CDKN1A, NCF1, CCNH, ITGB3, KIF14, CIB1, IGF1R, AKAP13, PDGFRB, ZFP91, OXSR1, MAPK8IP3, ERN1, KARS, ALS2, IL23A, JTB, LCP2, ADNP, EPHA1, ARHGEF5, VAC14, LRP8, THBS1, STK3, PPP2CA, CCNB1, CCL5, DVL3, NCKAP1L, RIPK1, CSK, ZNF622, CCL19, ECT2, MARK2, MAP3K3, PDE6H, XRCC5, TNFRSF10A, PILRB, CENPE, CD4, CDK5, TAOK2, KRAS, CALM3, CAMK1, CALM1, CALM2, EZH2]
GO:0010756;positive regulation of plasminogen activation;10.0;1.0;0.9152410118609203;9.628524252492122;819.0285373556242;7.9853141584524145;0.027412148067464264;0.8236103492792612;[CLEC3B]
GO:0070106;interleukin-27-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;7.379178354882098;0.00101047745553359;0.728290889492758;[EBI3, IL27]
GO:0042129;regulation of T cell proliferation;8.0;0.6696747006330769;0.7098373503165385;8.89763674394933;80.78677358774456;4.7664383335842135;0.002703860608605884;0.6187558780415471;[TFRC, CD80, GLMN, EBI3, IL27, PDCD1LG2, CORO1A, ITCH, CD4, TWSG1, IL6, HLA-DMB, IL23A, CCL5, HLA-DPB1, CTLA4, NCKAP1L, CCL19, CCR2, HLA-DPA1, HAVCR2]
GO:0038083;peptidyl-tyrosine autophosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;522.6399477532146;5.905872616772578;0.017492288705884526;0.7172676121338334;[FES, CSK, IGF1R]
GO:1904646;cellular response to amyloid-beta;7.0;1.0;0.8509193652572005;9.628524252492122;273.93391051768003;6.518977089658987;0.009168321460513012;0.6843001567857983;[CDK5, IGF1R]
GO:0006396;RNA processing;7.0;0.49247393176386933;0.5971563311391352;7.484544189674715;115.0816327851482;3.0330144413691222;0.0038516786825735262;0.5060278648384131;[AHCYL1, CCNH, POP4, INTS10, EIF4A3, DDX42, DDX41, CASC3, USP39, EFTUD2, UBL5, ALKBH5, ZC3H7A, PCF11, C1QBP, ARL6IP4, SNIP1, DHX16, ZNF326, RBM5, AQR, RPS9, WDR37, BUD31, SSU72, IMP4, TFIP11, THOC2, SRRM1, ERN1, KARS, PSPC1, PRPF3, FASTKD5, SNRPG, RPP21, CD2BP2, SLU7, RBMS2, TRUB2, SF3B5, SF3B2, POLDIP3, WBP4, DDX23, SUPT6H, PPP2CA, PABPN1, U2AF2, POLR2B, SNRPB2, POLR2G, EXOSC3, SMNDC1, CPSF6, PRPF38A, GPKOW, WTAP, INTS3, CPSF3, NONO, CPSF2, ADAT1, LSM5, GTF2H4, BYSL, SETX, PAN3, SON, LAS1L, INTS4, ACIN1]
GO:0002230;positive regulation of defense response to virus by host;8.0;1.0;0.875;9.628524252492122;73.08237040089334;6.599019797332524;0.0024460011674546805;0.712474179321389;[APOBEC3F, DTX3L, IL23A, IL27, TMEM173]
GO:0006359;regulation of transcription by RNA polymerase III;10.0;0.8436909121759173;0.837086467948879;9.52844079393514;248.56913769389934;6.481236761676141;0.008319385340914571;0.7466917612613706;[GTF3C1, ZNF143, TBP, ELL, POLR3C]
GO:1903955;positive regulation of protein targeting to mitochondrion;10.0;0.9326813400603323;0.8815816818910864;9.597752593825367;662.5702871444865;6.311337724880743;0.022175631236180954;0.7380031166185408;[NPEPPS, USP36, UBL5, VPS11, UBE2L3]
GO:0046328;regulation of JNK cascade;11.0;0.7866048967936545;0.8257314007264895;9.485423408851448;236.19920713085625;4.6122876537569555;0.00790537489718426;0.6683015574361036;[HDAC3, AMBP, NCF1, PTPN22, MAPK8IP3, STK3, IGF1R, ERN1, DUSP22, ITCH, SFRP1, COPS5, NCOR1, TAOK2, DVL3, RIPK1, ZNF622, CCL19, ARHGEF5, PAFAH1B1, DACT1]
GO:0048747;muscle fiber development;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;33.944966077546525;5.75172193694532;0.001136107466129388;0.6172636399279519;[NEBL]
GO:0009617;response to bacterium;5.0;0.7508913569872202;0.6656866903545304;8.935377071932177;27.267803904038782;3.9481280100702625;9.126288572378991E-4;0.49214846190264216;[ANKRD17, FGA, FCER1G, SEH1L, HIST1H2BJ, PPP1R11, CCL20, DEFB1, IL27, RNASE3, NLRC4, LYST, VIL1, CD4, IL6, IL23A, BCL3, NLRP3, HIST1H2BC, HAVCR2]
GO:0048791;calcium ion-regulated exocytosis of neurotransmitter;10.0;0.8933024483968273;0.861892236059334;9.551563211355994;176.6280078189881;6.343086423195323;0.005911580466814719;0.7396267465268138;[RPH3A, SYTL3]
GO:0006906;vesicle fusion;6.0;0.6799073451904818;0.6630739851853854;8.563813515499694;63.097974703971886;5.192106149009898;0.0021118324288514666;0.5886448625081389;[GOSR1, STX11, SYTL3, TAPBP, RPH3A, RAB20, VPS41, VPS8, VPS11, STX5, SNAP29, SPG11, VAMP5, RAB8B, SEC22C]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[NCF1, DEFB1, IL27, LYST, PPP6C, C1QBP, HAVCR2, FGA, FCER1G, DTX3L, WRNIP1, RNASE3, TMEM173, SIRT2, IL23A, ELF4, PSPC1, TRIM14, HIST1H2BC, ANKRD17, COLEC12, HIST1H2BJ, CFH, NLRC4, ZC3HAV1, LILRA2, CORO1A, RELA, C2, C3, PRDX1, SLAMF7, NLRP3, CSK, APOL1, APOBEC3F, APOBEC3H, XRCC5, NONO, NFKB1, ITCH, POLR3C, FES, POLR3E, PTX3, SERINC3, TRIM32, CD244, C1QC]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[AVEN, BTG2, CDKN1A, DOCK8, KIF14, CIB1, AATF, UBE2Z, IGF1R, NUP62, CFL1, CASP2, CTSH, SOX8, IER3, PDGFRB, TSC22D4, FGA, DFFA, FCER1G, CSNK2A1, SPHK2, SPHK1, FGG, PLAUR, FLT3LG, YWHAZ, DDB1, ITPKB, CREB3, SFRP1, CFDP1, PTRH2, VDAC2, ADNP, EPHA1, PPID, BECN1, HDAC3, HDAC1, NLRC4, THBS1, CORO1A, RELA, MTDH, CLN3, BAG3, CCL5, LMNA, NCKAP1L, RIPK1, CCL19, RFFL, SNCB, BID, NTSR1, TBX1, TFAP2A, PRELID1, UBE2B, EYA2, NONO, RHBDD1, SYVN1, TNFRSF10A, NFKB1, SETX, VIL1, NFKBIA, ITCH, IL6, SON, COPS5, TNIP2, BCL3, KRAS, ERCC5, PDCD1, TRIM32, MAD2L1, CPEB4]
GO:0070374;positive regulation of ERK1 and ERK2 cascade;11.0;0.9326813400603323;0.8987696223598284;9.604993755081928;1178.864923326294;4.330336256014159;0.03945554807418015;0.6538825498434562;[PDGFRB, FGA, CCL20, FGG, GPR55, CIB1, PTPN22, IGF1R, RAP1B, CD4, KARS, CCL5, CCL19, EPHA1, HAVCR2]
GO:0035329;hippo signaling;6.0;1.0;0.8231203125901445;9.628524252492122;26.42836680105094;6.375876246018314;8.845336528452411E-4;0.6491829203200885;[YWHAB, STK3]
GO:0017158;regulation of calcium ion-dependent exocytosis;9.0;0.6799073451904818;0.73619429777553;8.730582659286164;63.43514412564899;5.514393750639154;0.0021231171859622203;0.6782469780335098;[RAP1B, RPH3A, TRIM9, CDK5, SYTL3, RAB3GAP1]
